Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Geriatric pain relief

This article was originally published in The Tan Sheet

Executive Summary

Guidelines for pain relief in older adults issued by American Geriatrics Society are "misleading," Aspirin Foundation of America maintains in a May 8 statement. The AGS guidelines recommend against long-term use of aspirin and other nonsteroidal anti-inflammatory drugs, advising use of acetaminophen as first-line therapy for musculoskeletal pain; development of the guidelines was sponsored by McNeil Consumer Products, the maker of Tylenol ("The Tan Sheet" May 11, p. 9). AGS "failed to clearly distinguish between long-term daily use of prescription NSAIDs and the safe, occasional use of [OTC] medications such as aspirin and ibuprofen," AFA maintains. The foundation decries "what appeared to be a conflict of interest in the sponsorship of these guidelines." AGS' "blanket generalizations about NSAIDs target Tylenol's main competitors in the [OTC] pain reliever market," AFA asserts...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088438

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel